Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSERT: Antibiotics for SSI in Tissue Expander Breast Reconstruction
NCT04631185Completed
- Sponsor
- The Plastic Surgery Foundation
- Start
- May 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in surgical site infection (SSI), sponsored by The Plastic Surgery Foundation. Primary endpoint: Surgical Site Infection within 30 days. Started May 2021; status: completed.
02
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04631185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631185.